Bio-Rad Laboratories (BIO) Return on Capital Employed Growth (3y) (2013 - 2026)
Bio-Rad Laboratories (BIO) Return on Capital Employed Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1,679.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -846.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1,318.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -247.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Bio-Rad Laboratories | 8.53 Bn | 6.97 Bn | 309.40 Mn | -575.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -575.00 |
| Dec 31, 2025 | -835.00 |
| Sep 30, 2025 | 110.00 |
| Jun 30, 2025 | -7,819.00 |
| Mar 31, 2025 | -260.00 |
| Dec 31, 2024 | 84.00 |
| Mar 31, 2024 | 121,416.00 |
| Dec 31, 2023 | -172.00 |
| Sep 30, 2023 | 25.00 |
| Jun 30, 2023 | 11.00 |
| Mar 31, 2023 | 307.00 |
| Dec 31, 2022 | 540.00 |
| Sep 30, 2022 | 489.00 |
| Jun 30, 2022 | 535.00 |
| Mar 31, 2022 | 978.00 |
| Dec 31, 2021 | 713.00 |
| Sep 30, 2021 | 58.00 |
| Jun 30, 2021 | 80.00 |
| Mar 31, 2021 | 428.00 |
| Dec 31, 2020 | 475.00 |